INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/09/2026
Back to search
Official data from USPTO
MABYLON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MABYLON
ST13
US500000079227503Class
1, 5, 10, 42, 44
Filing
79227503
Registration
5558008
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/09/2026
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
11/16/2017
Registration date
09/11/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2025
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
CHHINA, KARANENDRA S
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Mabylon AG
Representatives
weber schaub & partner ag
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products for use in industry and science; biochemical productsantibodies for scientific or research useother than for medical use
Class 5
Pharmaceutical and veterinary products for the treatment of autoimmune related diseases and disorders and inflammatory related diseases and disorders; medical preparations for the treatment of immune diseasesprotein productshuman-derived monoclonal antibodiesantigens in the nature of cells for medical use; chemical preparations for medical use for the treatment of autoimmune related diseases and disorders and inflammatory related diseases and disorders as well as other acute or chronic conditions of unmet medical need; diagnostic substancespreparations and agents for medical use; diagnostic substances for medical use; medical preparations for the determination of biologically active substancesantiallergenic medical preparations and substances; medical and diagnostic preparations for enzyme determination
Class 10
Medical apparatus and instrumentsin particular for immune disease diagnosis or determination
Class 42
Scientific servicesscientific researchanalysistestingclinical trialsbiological research and antibody design services particularly relating to immune and autoimmune diseases; preparation of technical reports for therapeutic antibody discovery and development purposes; research regarding medicines; technological servicestechnological research and design in the field of therapeutic antibody discovery and development as well as research and new product design services relating thereto; industrial analysis and research services in the field of immune and inflammatory related diseases and disorders
Class 44
Medical and veterinary services; hygienic and beauty care for human beings or animals; services provided by consultants in the pharmaceutical field
Publications
History of USPTO decisions and trademark events.
25 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/24/2026
INPC
INVALIDATION PROCESSED
06/24/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/28/2025
C71T
CANCELLED SECTION 71
03/28/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/05/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/19/2018
FIMP
FINAL DISPOSITION PROCESSED
12/19/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/11/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
09/11/2018
PUBO
PUBLISHED FOR OPPOSITION
06/26/2018
NPUB
NOTICE OF PUBLICATION
06/06/2018
CNEA
EXAMINERS AMENDMENT MAILED
05/18/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/17/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
05/17/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/17/2018
RFNP
REFUSAL PROCESSED BY IB
03/31/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/15/2018
RFRR
REFUSAL PROCESSED BY MPU
03/15/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/09/2018
CNRT
NON-FINAL ACTION WRITTEN
03/08/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/06/2018
DOCK
ASSIGNED TO EXAMINER
02/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/22/2018
Continuous trademark protection
Get notified about every new filing that threatens MABYLON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.